Daiki Ikarashi

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Combination Therapy

Muscle Invasive Bladder Cancer

Top Venues

IJU case reports

Japanese journal of clinical oncology

British journal of cancer

World journal of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Moe Toyoshima, Daiki Ikarashi, Kie Sekiguchi, Tatsuya Kawamura, Arisa Machida, Takeshi Yamaguchi, Yumeka Arakawa, Akito Ito, Shigekatsu Maekawa, Wataru Obara
Parenchymal renal rupture due to an obstructive ureteric calculus in an incompletely duplicated renal pelvis and ureter. IJU case reports 7 (2) (2024)
Yuta Goto, Daichi Tamura, Tomohiko Matsuura, Ei Shiomi, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Wataru Obara
Successful treatment of eosinophilia associated with dialysis-related renal cancer with radical nephrectomy. IJU case reports 7 (4) (2024)
Ei Shiomi, Yuta Goto, Mizuki Hisano, Rento Ito, Makoto Moriwaka, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Takashi Ujiie, Wataru Obara
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis. IJU case reports 7 (2) (2024)
Yuta Goto, Daichi Tamura, Tomohiko Matsuura, Ei Shiomi, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Wataru Obara
Successful treatment of eosinophilia associated with dialysis-related renal cancer with radical nephrectomy. IJU case reports 7 (4) (2024)
Moe Toyoshima, Daiki Ikarashi, Kie Sekiguchi, Tatsuya Kawamura, Arisa Machida, Takeshi Yamaguchi, Yumeka Arakawa, Akito Ito, Shigekatsu Maekawa, Wataru Obara
Parenchymal renal rupture due to an obstructive ureteric calculus in an incompletely duplicated renal pelvis and ureter. IJU case reports 7 (2) (2024)
Shigekatsu Maekawa, Ryo Takata, Kie Sekiguchi, Masahiro Kagabu, Moe Toyoshima, Shinji Tamada, Kenta Takahashi, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, Yoichiro Kato, Mitsugu Kanehira, Jun Sugimura, Takaya Abe, Tsukasa Baba, Wataru Obara
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice. Japanese journal of clinical oncology 54 (4) (2024)
Ei Shiomi, Yuta Goto, Mizuki Hisano, Rento Ito, Makoto Moriwaka, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Takashi Ujiie, Wataru Obara
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis. IJU case reports 7 (2) (2024)
Kenta Takahashi, Renpei Kato, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara
Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review. IJU case reports 7 (2) (2023)
Shigekatsu Maekawa, Ryo Takata, Kie Sekiguchi, Masahiro Kagabu, Moe Toyoshima, Shinji Tamada, Kenta Takahashi, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, Yoichiro Kato, Mitsugu Kanehira, Jun Sugimura, Takaya Abe, Tsukasa Baba, Wataru Obara
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice. Japanese journal of clinical oncology (2023)
Kenta Takahashi, Renpei Kato, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara
Avelumab plus axitinib for translocation renal cell carcinoma: A case series and literature review. IJU case reports 7 (2) (2023)
Shinji Tamada, Daiki Ikarashi, Takashi Tsuyukubo, Kazuhiro Iwasaki, Kazumasa Isurugi, Sadahide Ono, Ryo Takata, Hiromitsu Fujisawa, Wataru Obara
Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases. IJU case reports 5 (6) (2022)
Daiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, Kazumasa Takenouchi, Takayuki Nakayama, Hiroko Onagi, Asumi Sakaguchi, Makiko Yamashita, Hidenori Mizugaki, Shigekatsu Maekawa, Renpei Kato, Yoichiro Kato, Tamotsu Sugai, Tetsuya Nakatsura, Wataru Obara
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting. British journal of cancer (2021)
Yoichiro Kato, Daiki Ikarashi, Daichi Kikuchi, Misato Takayama, Seiko Kanzaki, Akito Ito, Daichi Tamura, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Wataru Obara
Dysuria therapeutic agents as an independent prognostic factor for the primary recurrence of non-muscle invasive bladder cancer: a propensity score matching study. The Journal of international medical research 49 (8) (2021)
Daiki Ikarashi, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Akito Ito, Mitsutaka Onoda, Renpei Kato, Tomohiko Matsuura, Kazuhiro Iwasaki, Wataru Obara
Appropriate preoperative membranous urethral length predicts recovery of urinary continence after robot-assisted laparoscopic prostatectomy. World journal of surgical oncology 16 (1) (2018)